➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011963

Email this page to a colleague

« Back to Dashboard

NDA 011963 describes PHOSPHOLINE IODIDE, which is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the PHOSPHOLINE IODIDE profile page.

The generic ingredient in PHOSPHOLINE IODIDE is echothiophate iodide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the echothiophate iodide profile page.
Summary for 011963
Applicant:Wyeth Pharms
Ingredient:echothiophate iodide
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 011963
Suppliers and Packaging for NDA: 011963
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHOSPHOLINE IODIDE echothiophate iodide FOR SOLUTION;OPHTHALMIC 011963 NDA Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 0046-1065 0046-1065-05 1 KIT in 1 KIT (0046-1065-05) * 6.25 mL in 1 BOTTLE (0046-1465-05) * 5 mL in 1 BOTTLE (0046-1162-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;OPHTHALMICStrength0.125%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:FOR SOLUTION;OPHTHALMICStrength0.03%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:FOR SOLUTION;OPHTHALMICStrength0.25%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.